Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Committee on Advanced Therapies (CAT) celebrates its first birthday 27 januar 2010Press releaseAdvanced therapies European Medicines Agency launches consultation on its Road Map to 2015 26 januar 2010Press releaseMedicines European Medicines Agency gives first opinion on compassionate use 22 januar 2010Press releaseHumanMedicines European Medicines Agency updates on pandemic influenza 22 januar 2010Press releaseHumanMedicines European Medicines Agency recommends suspension of marketing authorisation for sibutramine 22 januar 2010Press releaseMedicines European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri 21 januar 2010Press releaseMedicines Janssen-Cilag International NV withdraws its marketing authorisation application for Comfyde (carisbamate) 20 januar 2010Press release Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 12-14 January 2010 15 januar 2010Press releaseVeterinary Wyeth Consumer Healthcare withdraws its marketing authorisation application for Ibuprofen/Diphenhydramine Hydrochloride Wyeth 13 januar 2010Press release Sanofi Aventis withdraws its marketing authorisation application for Sliwens (eplivanserin) 21 december 2009Press release 1 … 291 292 293 294 295 Page 295 of 380 296 297 298 299 … 380
Committee on Advanced Therapies (CAT) celebrates its first birthday 27 januar 2010Press releaseAdvanced therapies
European Medicines Agency launches consultation on its Road Map to 2015 26 januar 2010Press releaseMedicines
European Medicines Agency gives first opinion on compassionate use 22 januar 2010Press releaseHumanMedicines
European Medicines Agency recommends suspension of marketing authorisation for sibutramine 22 januar 2010Press releaseMedicines
European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri 21 januar 2010Press releaseMedicines
Janssen-Cilag International NV withdraws its marketing authorisation application for Comfyde (carisbamate) 20 januar 2010Press release
Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 12-14 January 2010 15 januar 2010Press releaseVeterinary
Wyeth Consumer Healthcare withdraws its marketing authorisation application for Ibuprofen/Diphenhydramine Hydrochloride Wyeth 13 januar 2010Press release
Sanofi Aventis withdraws its marketing authorisation application for Sliwens (eplivanserin) 21 december 2009Press release